SCHEMBL3824183

SCHEMBL3824183

CNc1ccc(-c2[nH]c(-c3ccccc3/C=C/c3nc4ccccc4o3)nc2-c2ccc(N(C)C)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOX1 Q9Y5S8 1/20 0.45
▸ MAPT P10636 3/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ ALOX5 P09917 2/20 0.37
▸ NPC1 O15118 5/20 0.37
▸ RAB9A P51151 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MGAM O43451 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ HCRTR1 O43613 1/20 0.32
▸ NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6609826 0.94 NOX1 (0.51) NOX1MAPTRXFP1ALOX5NPC1
SCHEMBL3830694 0.91 MEN1 (0.37) NOX1MAPTNPC1RAB9AMEN1
SCHEMBL3828923 0.87 NOX1 (0.40) NOX1MAPTRXFP1ALOX5NPC1
SCHEMBL3825381 0.85 KDM4E (0.36) MAPTALOX5NPC1RAB9AMEN1
SCHEMBL8720952 0.82 MAPT (0.43) NOX1MAPTRXFP1ALOX5NPC1
SCHEMBL3826536 0.81 MEN1 (0.48) NOX1MAPTALOX5NPC1RAB9A
SCHEMBL6607624 0.73 MEN1 (0.55) NOX1MAPTALOX5NPC1RAB9A
SCHEMBL8723120 0.73 MAPT (0.36) MAPTRXFP1NPC1RAB9AMEN1
SCHEMBL8718582 0.68 KDM4E (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL29397958 0.68 MEN1 (0.59) MAPTRXFP1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
EP-0999835-A4 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORP (US) 2004-08-25 — — EP disclosed
EP-0999835-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS Ontogen Corporation (US) 2000-05-17 — — EP disclosed
WO-1999002155-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORPORATION (US) 1999-01-21 — — WO disclosed
Send feedback